Marshall Wace, LLP Beauty Health CO Transaction History

Marshall Wace, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$10.35 - $15.27 $12 Million - $17.7 Million	1,160,932 Added 6910.31%	1,177,732 $13.9 Million
Q2 2022 Aug 15, 2022	SELL	$10.6 - $17.48 $13.2 Million - $21.8 Million	-1,249,085 Reduced 98.67%	16,800 $217,000
Q1 2022 May 16, 2022	SELL	$12.24 - $24.07 $21.6 Million - $42.4 Million	-1,762,053 Reduced 58.19%	1,265,885 $21.4 Million
Q4 2021 Feb 14, 2022	SELL	$20.7 - $29.49 $22.5 Million - $32 Million	-1,085,492 Reduced 26.39%	3,027,938 $73.2 Million
Q3 2021 Nov 15, 2021	BUY	$16.76 - $28.26 $68.9 Million - $116 Million	4,113,430 New	4,113,430 $107 Million
Q2 2021 Aug 13, 2021	SELL	$9.91 - $18.8 $172,751 - $327,721	-17,432 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.25 - $11.53 $178,678 - $200,990	17,432 New	17,432 $188,000

129

54.8M

3.71M

394K

Ticker SKIN
Exchange NASDAQ
Sector Consumer Defensive
Industry Household & Personal Products
Shares Outstandng 150,887,008
Market Cap $235M
Description
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Hydra...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.